Overview
Denis Chemla practices in Paris, France. Mr. Chemla is rated as an Advanced expert by MediFind in the treatment of Transthyretin Amyloidosis. His top areas of expertise are Pulmonary Hypertension, Hypertension, Transthyretin Amyloidosis, Pulmonary Embolism, and Lung Transplant.
His clinical research consists of co-authoring 89 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles in the study of Transthyretin Amyloidosis.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Pulmonary HypertensionMr. Chemla isElite. Learn about Pulmonary Hypertension.
- Distinguished
- HypertensionMr. Chemla isDistinguished. Learn about Hypertension.
- Advanced
- Transthyretin AmyloidosisMr. Chemla isAdvanced. Learn about Transthyretin Amyloidosis.
- Experienced
- Cardiac AmyloidosisMr. Chemla isExperienced. Learn about Cardiac Amyloidosis.
- Central Sleep ApneaMr. Chemla isExperienced. Learn about Central Sleep Apnea.
- Familial Transthyretin AmyloidosisMr. Chemla isExperienced. Learn about Familial Transthyretin Amyloidosis.
- Heart FailureMr. Chemla isExperienced. Learn about Heart Failure.
- Heart Failure with Preserved Ejection Fraction (HFpEF)
- Low Blood PressureMr. Chemla isExperienced. Learn about Low Blood Pressure.